Dr. J. Craig Venter, one of the first scientists to sequence the human genome and the co-founder of biotech firm Human Longevity, describes the next frontier of DNA-driven research and how it will revolutionize the health care industry.
The scientist describes a new examination using DNA testing that uncovered cancer in patients long before it would have shown up using current methods.
"We are learning that we are DNA-software driven species, and that your software determines everything about your life, including how long you are going to live," said Venter.
By analyzing people's genetic code, the scientist hopes to find new pharmaceutical procedures that could predict and even cure some of today's most devastating diseases.
CNBC PRO subscribers have access to this exclusive interview, which was originally broadcast on "Squawk Box."
